A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase

FASEB Journal

Volumn 27, Issue 11, 2013, Pages 4476-4488

  Dangel, Alexandra ^a   Ackermann, Nikolaus ^b   Abdel Hadi, Omar ^c   Maier, Richard ^c   Önder, Kamil ^c   Francois, Patrice ^d   Müller, Carsten W ^e   Pané Farré, Jan ^f   Engelmann, Susanne ^f   Schrenzel, Jacques ^d   Heesemann, Jürgen ^b   Lindermayr, Christian ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

B Transcription factor; DNA binding; NanoSIMS

Indexed keywords

AMINO ACID; PHOSPHOTRANSFERASE; POLYPEPTIDE ANTIBIOTIC AGENT; RSBW KINASE; SP1 1; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CELL WALL; CONTROLLED STUDY; DELETION MUTANT; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME BINDING; GENETIC TRANSCRIPTION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ΣB TRANSCRIPTION FACTOR; DNA BINDING; NANOSIMS;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SIGMA FACTOR; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC; VIRULENCE;

EID: 84887113318     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-234575     Document Type: Article

References (72)

1. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250 (Pubitemid 40298223)
2. Mangoni, M. L. (2011) Host-defense peptides: from biology to therapeutic strategies. Cell. Mol. Life Sci. 68, 2157-2159
3. Andres, E. (2012) Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin. Eur. J. Clin. Microbiol. Infect. Dis. 31, 881-888
4. Laverty, G., and Gorman., S. P., and Gilmore, B. F. (2011) The potential of antimicrobial peptides as biocides. Int. J. Mol. Sci. 12, 6566-6596
5. Nguyen, L. T., and Haney., E. F., and Vogel, H. J. (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29, 464-472
6. Steiner, H., Hultmark, D., Engstrom, A., Bennich, H., and Boman, H. G. (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292, 246-248 (Pubitemid 11001840)
7. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U. S. A. 84, 5449-5453 (Pubitemid 17129018)
8. Bulet, P., Stocklin, R., and Menin, L. (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198, 169-184 (Pubitemid 38406943)
9. Garcia-Olmedo, F., Molina, A., and Alamillo., J. M., and Rodriguez-Palenzuela, P. (1998) Plant defense peptides. Biopolymers 47, 479-491
10. Peschel, A., and Sahl, H. G. (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529-536 (Pubitemid 43905612)
11. Giuliani, A., Pirri, G., and Nicoletto, S. F. (2007) Antimicrobial peptides: an overview of a promising class of therapeutics. Central Eur. J. Biol. 2, 1-33 (Pubitemid 46450753)
12. Park, C. B., and Kim., H. S., and Kim, S. C. (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244, 253-257 (Pubitemid 28419934)
13. Patrzykat, A., and Friedrich., C. L., Zhang, L., Mendoza, V., and Hancock, R. E. (2002) Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46, 605-614 (Pubitemid 34162506)
14. Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., and Otvos, L., Jr. (2001) The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaper-one-assisted protein folding. Biochemistry 40, 3016-3026 (Pubitemid 32206189)
15. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H., and Gudmundsson, G. H. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093
16. Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., and Nielsen., A. K., Mygind, P. H., Raventos, D. S., Neve, S., Ravn, B., Bonvin, A. M., De Maria, L., Andersen, A. S., Gammelgaard, L. K., Sahl, H. G., and Kristensen, H. H. (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328, 1168-1172
17. Livermore, D. M. (2004) The need for new antibiotics. Clin. Microbiol. Infect. 10(Suppl. 4), 1-9
18. Wilke, M. H. (2010) Multiresistant bacteria and current therapy: the economical side of the story. Eur. J. Med. Res. 15, 571-576
19. Sinha, B., and Fraunholz, M. (2010) Staphylococcus aureus host cell invasion and post-invasion events. Int. J. Med. Microbiol. 300, 170-175
20. Chambers, H. F., and Deleo, F. R. (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641
21. Wiegand, I., Hilpert, K., and Hancock, R. E. (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163-175 (Pubitemid 351266501)
22. Pietiainen, M., Francois, P., Hyyrylainen, H. L., Tangomo, M., Sass, V., Sahl, H. G., Schrenzel, J., and Kontinen, V. P. (2009) Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10, 429
23. Charbonnier, Y., Gettler, B., Francois, P., Bento, M., Renzoni, A., Vaudaux, P., Schlegel, W., and Schrenzel, J. (2005) A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus. BMC Genomics 6, 95
24. Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, A., Aoki, K., Nagai, Y., Lian, J., Ito, T., Kanamori, M., Matsumaru, H., Maruyama, A., Murakami, H., Hosoyama, A., Mizutani-Ui, Y., Takahashi, N. K., Sawano, T., Inoue, R., Kaito, C., Sekimizu, K., Hirakawa, H., Kuhara, S., Goto, S., Yabuzaki, J., Kanehisa, M., Yamashita, A., Oshima, K., Furuya, K., Yoshino, C., Shiba, T., Hattori, M., Ogasawara, N., Hayashi, H., and Hiramatsu, K. (2001) Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357, 1225-1240 (Pubitemid 32539050)
25. Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., Kuroda, H., Cui, L., Yamamoto, K., and Hiramatsu, K. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359, 1819-1827 (Pubitemid 34607058)
26. Gill, S. R., and Fouts., D. E., Archer, G. L., Mongodin, E. F., and Deboy., R. T., Ravel, J., Paulsen, I. T., and Kolonay., J. F., Brinkac, L., Beanan, M., Dodson, R. J., Daugherty, S. C., Madupu, R., Angiuoli, S. V., Durkin, A. S., Haft, D. H., Vamathevan, J., Khouri, H., Utterback, T., Lee, C., Dimitrov, G., Jiang, L., Qin, H., Weidman, J., Tran, K., Kang, K., Hance, I. R., Nelson, K. E., and Fraser, C. M. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187, 2426-2438 (Pubitemid 40389140)
27. Gillaspy, A. F., Worell, V., Orvis, J., Roe, B. A., and Dyer, D. W. (2007) Staphylococcus aureus subsp. aureus NCTC 8325, complete genome. National Center for Biotechnology Information Database, Bethesda, MD, USA; http://www.ncbi.nlm.nih.gov/bioproject?cmd=Retrieve&dopt=Overview&uid= 237
28. Diep, B. A., and Gill., S. R., Chang, R. F., Phan, T. H., and Chen., J. H., Davidson, M. G., Lin, F., Lin, J., and Carleton., H. A., Mongodin, E. F., Sensabaugh, G. F., and Perdreau-Remington, F. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367, 731-739 (Pubitemid 43326291)
29. Holden, M. T., and Feil., E. J., Lindsay, J. A., Peacock, S. J., and Day., N. P., Enright, M. C, Foster, T. J., and Moore., C. E., Hurst, L., Atkin, R., Barron, A., Bason, N., Bentley, S. D., Chillingworth, C, Chillingworth, T., Churcher, C, Clark, L., Corton, C, Cronin, A., Doggett, J., Dowd, L., Feltwell, T., Hance, Z., Harris, B., Hauser, H., Holroyd, S., Jagels, K., James, K. D., Lennard, N., Line, A., Mayes, R., Moule, S., Mungall, K., Ormond, D., Quail, M. A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Sharp, S., Simmonds, M., Stevens, K., Whitehead, S., Barrell, B. G., Spratt, B. G., and Parkhill, J. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101, 9786-9791 (Pubitemid 38869314)
30. Baba, T., Bae, T., Schneewind, O., Takeuchi, F., and Hiramatsu, K. (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J. Bacteriol. 190, 300-310
31. Scherl, A., Francois, P., Charbonnier, Y., Deshusses, J. M., Koessler, T., Huyghe, A., Bento, M., Stahl-Zeng, J., Fischer, A., Masselot, A., Vaezzadeh, A., Galle, F., Renzoni, A., Vaudaux, P., Lew, D., Zimmermann-Ivol, C. G., Binz, P. A., Sanchez, J. C, Hochstrasser, D. F., and Schrenzel, J. (2006) Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers. BMC Genomics 7, 296
32. Brandner, C. J., and Maier., R. H., Henderson, D. S., Hintner, H., Bauer, J. W., and Onder, K. (2008) The ORFeome of Staphylococcus aureus v 1.1. BMC Genomics 9, 321
33. Walhout, A. J., and Temple., G. F., Brasch, M. A., Hartley, J. L., and Lorson., M. A., van den Heuvel, S., and Vidal, M. (2000) GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol. 328, 575-592
34. Hartley, J. L., and Temple., G. F., and Brasch, M. A. (2000) DNA cloning using in vitro site-specific recombination. Genome Res. 10, 1788-1795
35. Maier, R., Brandner, C, Hintner, H., Bauer, J., and Onder, K (2008) Construction of a reading frame-independent yeast two-hybrid vector system for site-specific recombinational cloning and protein interaction screening. BioTechniques 45, 235-244
36. Pane-Farre, J., Jonas, B., and Hardwick., S. W., Gronau, K., Lewis, R J., Hecker, M., and Engelmann, S. (2009) Role of RsbU in controlling SigB activity in Staphylococcus aureus following alkaline stress. J. Bacteriol. 191, 2561-2573
37. Herbert, S., and Ziebandt., A. K., Ohlsen, K., Schafer, T., Hecker, M., Albrecht, D., Novick, R., and Gotz, F. (2010) Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect. Immun. 78, 2877-2889
38. Musat, N., Halm, H., Winterholler, B., Hoppe, P., Peduzzi, S., Hillion, F., Horreard, F., Amann, R., Jorgensen, B. B., and Kuypers, M. M. (2008) A single-cell view on the ecophysiology of anaerobic phototrophic bacteria. Proc. Natl. Acad. Sci. U. S. A. 105, 17861-17866
39. Guerquin-Kern, J. L., Wu, T. D., Quintana, C, and Croisy, A (2005) Progress in analytical imaging of the cell by dynamic secondary ion mass spectrometry (SIMS microscopy). Biochim. Biophys. Acta 1724, 228-238 (Pubitemid 41080032)
40. Cameca (2009) NanoSIMS 50/50L instrumentation [16 pp. booklet], Cameca SAS, Genevilliers, France; http://www.cameca.com/literature/product-brochures. aspx
41. Musat, N., Foster, R., Vagner, T., Adam, B., and Kuypers, M. M. (2012) Detecting metabolic activities in single cells, with emphasis on nanoSIMS. FEMS Microbiol. Rev. 36, 486-511
42. Kim, J. Y., and Park., S. C., Yoon, M. Y., Hahm, K. S., and Park, Y. (2011) C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria. Amino Acids 40, 183-195
43. Zeng, X. C., Wang, S., Nie, Y., Zhang, L., and Luo, X. (2012) Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides. Peptides 33, 44-51
44. Wang, G., and Epand., R. F., Mishra, B., Lushnikova, T., Thomas, V. C., and Bayles., K. W., and Epand, R. M. (2012) Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37. Antimicrob. Agents Chemother. 56, 845-856
45. Chen, Z., Wang, D., Cong, Y., Wang, J., Zhu, J., Yang, J., Hu, Z., Hu, X., Tan, Y., Hu, F., and Rao, X. (2011) Recombinant antimicrobial peptide hPAB-beta expressed in Pichia pastoris, a potential agent active against methicillin-resistant Staphylococcus aureus. Appl. Microbiol. Biotechnol. 89, 281-291
46. Yeaman, M. R., and Yount, N. Y. (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55 (Pubitemid 36268398)
47. Markossian, K. A., and Zamyatnin., A. A., and Kurganov, B. I. (2004) Antibacterial proline-rich oligopeptides and their target proteins. Biochemistry (Mosc.) 69, 1082-1091
48. Couto, M. A., and Harwig., S. S., and Lehrer, R. I. (1993) Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect. Immun. 61, 2991-2994 (Pubitemid 23182298)
49. King-Scott, J., Konarev, P. V., Panjikar, S., Jordanova, R., Svergun, D. I., and Tucker, P. A. (2011) Structural characterization of the multidomain regulatory protein Rv1364c from Mycobacterium tuberculosis. Structure 19, 56-69
50. Hecker, M., Pane-Farre, J., and Volker, U. (2007) SigB-dependent general stress response in Bacillus subtilis and related gram-positive bacteria. Annu. Rev. Microbiol. 61, 215-236 (Pubitemid 350058207)
51. Senn, M. M., Giachino, P., Homerova, D., Steinhuber, A., Strassner, J., Kormanec, J., Fluckiger, U., Berger-Bachi, B., and Bischoff, M. (2005) Molecular analysis and organization of the sigmaB operon in Staphylococcus aureus. J. Bacteriol. 187, 8006-8019 (Pubitemid 41691694)
52. Miyazaki, E., and Chen., J. M., Ko, C., and Bishai, W. R. (1999) The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB. J. Bacteriol. 181, 2846-2851 (Pubitemid 29211102)
53. Kullik, I., Giachino, P., and Fuchs, T. (1998) Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180, 4814-4820 (Pubitemid 28429367)
54. Pane-Farre, J., Jonas, B., Forstner, K., Engelmann, S., and Hecker, M. (2006) The sigmaB regulon in Staphylococcus aureus and its regulation. Int. J. Med. Microbiol. 296, 237-258 (Pubitemid 44016170)
55. Park, C. B., and Kim., M. S., and Kim, S. C. (1996) A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 218, 408-413 (Pubitemid 26037116)
56. Otvos, L., Jr., O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., and Blaszczyk-Thurin, M. (2000) Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39, 14150-14159
57. Behrens, S., Kappler, A., and Obst, M. (2012) Linking environmental processes to the in situ functioning of microorganisms by high-resolution secondary ion mass spectrometry (Nano-SIMS) and scanning transmission X-ray microscopy (STXM). Environ. Microbiol. 14, 2851-2869
58. Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., Berger-Bachi, B., and Projan, S. (2004) Microar-ray-based analysis of the Staphylococcus aureus sigmaB regulon. J. Bacteriol. 186, 4085-4099 (Pubitemid 38802556)
59. Hecker, M., Reder, A., Fuchs, S., Pagels, M., and Engelmann, S. (2009) Physiological proteomics and stress/starvation responses in Bacillus subtilis and Staphylococcus aureus. Res. Microbiol. 160, 245-258
60. Chen, H. Y., and Chen., C. C., Fang, C. S., Hsieh, Y. T., and Lin., M. H., and Shu, J. C. (2011) Vancomycin activates sigma in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity. PLoS ONE 6, e24472
61. Cebrian, G., Sagarzazu, N., Aertsen, A., Pagan, R., Condon, S., and Manas, P. (2009) Role of the alternative sigma factor sigma on Staphylococcus aureus resistance to stresses of relevance to food preservation. J. Appl. Microbiol. 107, 187-196
62. Stapleton, M. R., and Horsburgh., M. J., Hayhurst, E. J., Wright, L., Jonsson, I. M., Tarkowski, A., Kokai-Kun, J. F., Mond, J. J., and Foster, S. J. (2007) Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J. Bacteriol. 189, 7316-7325 (Pubitemid 47557346)
63. Diemond-Hernandez, B., Solorzano-Santos, F., Leanos-Miranda, B., Peregrino-Bejarano, L., and Miranda-Novales, G. (2010) Production of icaADBC-encoded polysaccharide intercellular adhesin and therapeutic failure in pediatric patients with Staphylococcal device-related infections. BMC Infect. Dis. 10, 68
64. Knobloch, J. K., Jager, S., Horstkotte, M. A., Rohde, H., and Mack, D. (2004) RsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaR. Infect. Immun. 72, 3838-3848 (Pubitemid 38821896)
65. Lauderdale, K. J., and Boles., B. R., Cheung, A. L., and Horswill, A. R. (2009) Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect. Immun. 77, 1623-1635
66. Giachino, P., Engelmann, S., and Bischoff, M. (2001) Sigma(B) activity depends on RsbU in Staphylococcus aureus. J. Bacteriol. 183, 1843-1852 (Pubitemid 32225979)
67. Dubrac, S., and Boneca., I. G., Poupel, O., and Msadek, T. (2007) New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189, 8257-8269 (Pubitemid 350178938)
68. Delaune, A., Dubrac, S., Blanchet, C., Poupel, O., Mader, U., Hiron, A., Leduc, A., Fitting, C., Nicolas, P., Cavaillon, J. M., Adib-Conquy, M., and Msadek, T. (2012) The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect. Immun. 80, 3438-3453
69. Gotoh, Y., Eguchi, Y., Watanabe, T., Okamoto, S., Doi, A., and Utsumi, R. (2010) Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opinion Microbiol. 13, 232-239
70. Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., and Appel., R. D., and Bairoch, A. (2003) ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784-3788 (Pubitemid 37442246)
71. Eisenberg, D. (1984) Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53, 595-623
72. Kneller, D. G., and Cohen., F. E., and Langridge, R. (1990) Improvements in protein secondary structure prediction by an enhanced neural network. J. Mol. Biol. 214, 171-182 (Pubitemid 20231217)